Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SIHUAN-PHARMACEUTICAL-HOL-6797640/news/National-Medical-Products-Administration-genehmigt-IND-Antrag-fur-Insulin-Degludec-und-Liraglutid-I-45146900/?utm_source=whatsapp&utm_medium=social&utm_campaign=share